Your session is about to expire
← Back to Search
Transcranial Direct Current Stimulation for Schizophrenia
Study Summary
This trial is testing whether transcranial direct current stimulation (tDCS) can help people with schizophrenia better understand and use cognitive control, a process that is essential for goal-directed behavior. tDCS is a noninvasive method of applying a weak electrical current to the brain. The study will also use functional magnetic resonance imaging (fMRI) to examine the effects of tDCS on the neuronal mechanisms of cognitive control in schizophrenia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 & 3 trial • 160 Patients • NCT02483468Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have made changes to your psychiatric medication within the past month.You have a device implanted in your brain to stimulate it.You have skin damage or conditions like eczema where the electrodes will be placed.You have had a recent injury to your head.You have a device called a defibrillator implanted in your body.You have epilepsy, a condition that causes seizures.You have a brain or nerve-related condition.You have metallic implants in your body.You have a condition called mental retardation, which affects your thinking and learning abilities.You have a pacemaker.You have vision problems that make it difficult for you to complete cognitive tests or tasks that require distinguishing colors.You have been diagnosed with schizophrenia, schizophreniform disorder, or schizoaffective disorder.
- Group 1: Experimental Stimulation
- Group 2: Sham Stimulation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the enrollment criteria encompass individuals up to age 80?
"The enrollment requirements for this trial necessitate that participants are at least 18 and not beyond 35 years of age."
What is the enrollment capacity of this clinical trial?
"Affirmative. The information available on clinicaltrials.gov states that the research is still recruiting patients, having initially been posted on April 1st 2017 and last updated August 3rd 2022. This study seeks to recruit 100 participants from a single medical site."
Could I potentially qualify for this research endeavor?
"This clinical trial seeks 100 young individuals aged 18 to 35 who suffer from schizophrenia, schizophreniform disorder, or schizoaffective disorder. To be considered for this study, a participant must possess adequate English literacy in order to understand and complete assigned tasks; they should also have the legal capacity to issue valid informed consent. Additionally, all participants need to maintain stable outpatient or partial hospital status throughout the course of the experiment."
Is participation in this clinical trial available to the public at present?
"The investigation, which was initially posted on April 1st 2017 and modified most recently on August 3rd 2022, is actively searching for participants according to clinicaltrials.gov."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger